Multiple endocrine neoplasia type 1.

Area of Science:

• Endocrinology
• Genetics
• Oncology

Background:

• Multiple endocrine neoplasia type 1 (MEN1) is an autosomal-dominant disorder.
• It is caused by mutations in the MEN1 tumor suppressor gene, encoding the menin protein.
• MEN1 is characterized by tumors of the parathyroid, pancreatic islet, and anterior pituitary glands, with potential for other tumors like carcinoids and adrenocortical tumors.

Purpose of the Study:

• To highlight the implications of MEN1 diagnosis for affected families.
• To discuss the challenges in managing MEN1-associated tumors.
• To emphasize the importance of early detection and specialized care for improving patient prognosis.

Main Methods:

• Review of the genetic basis of MEN1.
• Analysis of clinical characteristics and tumor behavior in MEN1 patients.
• Discussion of current treatment outcomes and prognostic factors.

Main Results:

• MEN1 diagnosis has significant implications for first-degree relatives, with a 50% risk of inheritance.
• MEN1 patients often face decreased life expectancy due to aggressive, treatment-resistant tumors and metastases.
• Current treatments for MEN1 tumors are often less successful than for sporadic tumors.

Conclusions:

• Pre-symptomatic tumor detection and MEN1-specific treatments may improve prognosis.
• Multidisciplinary team care involving specialists experienced in endocrine tumors is recommended for optimal management.
• Genetic analysis of the MEN1 gene is crucial for identifying at-risk family members.